TGF-β controls stromal telomere length through epigenetic modifications

Area of Science:

• Epigenetics
• Cancer Biology
• Molecular Oncology

Background:

• Telomere length is crucial for cellular function and is epigenetically regulated.
• Altered telomere length in cancer and stromal cells is linked to prostate cancer progression and metastasis.
• Transforming growth factor-beta (TGF-β) signaling influences prostate tumorigenesis, but its role in stromal telomere regulation is unclear.

Purpose of the Study:

• To investigate the role of TGF-β in regulating telomere length in prostate fibroblasts.
• To elucidate the molecular mechanisms underlying TGF-β-mediated telomere regulation.
• To explore the interplay between TGF-β, Notch, and androgen signaling in stromal telomere maintenance.

Main Methods:

• Utilized real-time reverse transcription-polymerase chain reaction (RT-PCR) for telomere length measurement.
• Assessed the expression of histone methyltransferase Suv39h1.
• Investigated the effects of DAPT (Notch inhibitor) and bicalutamide (antiandrogen) on stromal telomere length.

Main Results:

• TGF-β was found to regulate telomere length in mouse and human prostate fibroblasts.
• TGF-β increased the expression of Suv39h1, affecting histone methylation at telomeric ends.
• Notch and androgen signaling pathways were shown to cooperate with TGF-β in regulating stromal telomere length.

Conclusions:

• TGF-β plays a significant role in regulating prostate stromal cell telomere length via Suv39h1-mediated epigenetic modifications.
• The findings highlight a novel mechanism involving TGF-β, Notch, and androgen signaling in prostate cancer progression.
• Understanding stromal telomere regulation offers promising avenues for prostate cancer diagnosis, prognosis, and therapeutic development.